Literature DB >> 28647049

Targeting of regulated necrosis in kidney disease.

Diego Martin-Sanchez1, Jonay Poveda1, Miguel Fontecha-Barriuso1, Olga Ruiz-Andres1, María Dolores Sanchez-Niño1, Marta Ruiz-Ortega1, Alberto Ortiz1, Ana Belén Sanz2.   

Abstract

The term acute tubular necrosis was thought to represent a misnomer derived from morphological studies of human necropsies and necrosis was thought to represent an unregulated passive form of cell death which was not amenable to therapeutic manipulation. Recent advances have improved our understanding of cell death in acute kidney injury. First, apoptosis results in cell loss, but does not trigger an inflammatory response. However, clumsy attempts at interfering with apoptosis (e.g. certain caspase inhibitors) may trigger necrosis and, thus, inflammation-mediated kidney injury. Second, and most revolutionary, the concept of regulated necrosis emerged. Several modalities of regulated necrosis were described, such as necroptosis, ferroptosis, pyroptosis and mitochondria permeability transition regulated necrosis. Similar to apoptosis, regulated necrosis is modulated by specific molecules that behave as therapeutic targets. Contrary to apoptosis, regulated necrosis may be extremely pro-inflammatory and, importantly for kidney transplantation, immunogenic. Furthermore, regulated necrosis may trigger synchronized necrosis, in which all cells within a given tubule die in a synchronized manner. We now review the different modalities of regulated necrosis, the evidence for a role in diverse forms of kidney injury and the new opportunities for therapeutic intervention.
Copyright © 2017 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Acute rejection; Apoptosis; Chronic kidney disease; Delayed graft function; Enfermedad renal crónica; Ferroptosis; Función retardada del injerto; Kidney; Lesión renal aguda; Necroptosis; Rechazo agudo; Riñón; Transplantation; Trasplante

Mesh:

Substances:

Year:  2017        PMID: 28647049     DOI: 10.1016/j.nefro.2017.04.004

Source DB:  PubMed          Journal:  Nefrologia (Engl Ed)        ISSN: 2013-2514


  15 in total

Review 1.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

2.  TWEAK and RIPK1 mediate a second wave of cell death during AKI.

Authors:  Diego Martin-Sanchez; Miguel Fontecha-Barriuso; Susana Carrasco; Maria Dolores Sanchez-Niño; Anne von Mässenhausen; Andreas Linkermann; Pablo Cannata-Ortiz; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz; Ana Belen Sanz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-27       Impact factor: 11.205

Review 3.  The Future of IL-1 Targeting in Kidney Disease.

Authors:  Baris Afsar; Adrian Covic; Alberto Ortiz; Rengin Elsurer Afsar; Mehmet Kanbay
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

4.  Caspase-independent programmed cell death triggers Ca2PO4 deposition in an in vitro model of nephrocalcinosis.

Authors:  Giovanna Priante; Federica Quaggio; Lisa Gianesello; Monica Ceol; Rosalba Cristofaro; Liliana Terrin; Claudio Furlan; Dorella Del Prete; Franca Anglani
Journal:  Biosci Rep       Date:  2018-01-17       Impact factor: 3.840

5.  Quercetin alleviates acute kidney injury by inhibiting ferroptosis.

Authors:  Yue Wang; Fei Quan; Qiuhua Cao; Yanting Lin; Chongxiu Yue; Ran Bi; Xinmeng Cui; Hongbao Yang; Yong Yang; Lutz Birnbaumer; Xianjing Li; Xinghua Gao
Journal:  J Adv Res       Date:  2020-07-22       Impact factor: 10.479

Review 6.  Molecular Mechanisms of Kidney Injury and Repair.

Authors:  Sandra Rayego-Mateos; Laura Marquez-Expósito; Raquel Rodrigues-Diez; Ana B Sanz; Roser Guiteras; Nuria Doladé; Irene Rubio-Soto; Anna Manonelles; Sergi Codina; Alberto Ortiz; Josep M Cruzado; Marta Ruiz-Ortega; Anna Sola
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 7.  Folic acid-induced animal model of kidney disease.

Authors:  Liang-Jun Yan
Journal:  Animal Model Exp Med       Date:  2021-11-24

8.  Renal Dopamine Oxidation and Inflammation in High Salt Fed Rats.

Authors:  Anees A Banday; Mustafa F Lokhandwala
Journal:  J Am Heart Assoc       Date:  2019-12-27       Impact factor: 5.501

9.  Molecular pathways driving omeprazole nephrotoxicity.

Authors:  Miguel Fontecha-Barriuso; Diego Martín-Sanchez; Julio M Martinez-Moreno; Daniela Cardenas-Villacres; Susana Carrasco; Maria D Sanchez-Niño; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Redox Biol       Date:  2020-02-12       Impact factor: 11.799

10.  Effects and molecular mechanism of pachymic acid on ferroptosis in renal ischemia reperfusion injury.

Authors:  Gui-Ping Jiang; Yue-Juan Liao; Li-Li Huang; Xu-Jia Zeng; Xiao-Hui Liao
Journal:  Mol Med Rep       Date:  2020-11-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.